These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9120266)

  • 1. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45.
    Kozieradzki I; Kündig T; Kishihara K; Ong CJ; Chiu D; Wallace VA; Kawai K; Timms E; Ionescu J; Ohashi P; Marth JD; Mak TW; Penninger JM
    J Immunol; 1997 Apr; 158(7):3130-9. PubMed ID: 9120266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the level of CD45 surface expression affect the outcome of thymic selection.
    Wallace VA; Penninger JM; Kishihara K; Timms E; Shahinian A; Pircher H; Kündig TM; Ohashi PS; Mak TW
    J Immunol; 1997 Apr; 158(7):3205-14. PubMed ID: 9120275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.
    Zapata JM; Pulido R; Acevedo A; Sánchez-Madrid F; de Landázuri MO
    J Immunol; 1994 Apr; 152(8):3852-61. PubMed ID: 8144955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct differentiative stages of CD4+CD8+ thymocyte development defined by the lack of coreceptor binding in positive selection.
    Dutz JP; Ong CJ; Marth J; Teh HS
    J Immunol; 1995 Mar; 154(6):2588-99. PubMed ID: 7533178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cell hyper-responsiveness in CD45 transgenic mice is independent of isoform.
    Salmond RJ; McNeill L; Holmes N; Alexander DR
    Int Immunol; 2008 Jul; 20(7):819-27. PubMed ID: 18448457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged expression of high molecular mass CD45RA isoform during the differentiation of human progenitor thymocytes to CD3+ cells in vitro.
    Deans JP; Wilkins JA; Caixia S; Pruski E; Pilarski LM
    J Immunol; 1991 Dec; 147(12):4060-8. PubMed ID: 1836475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD45 isoform expression during T cell development in the thymus.
    Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H
    Eur J Immunol; 1992 Jul; 22(7):1843-50. PubMed ID: 1378021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8 inhibits signal transduction through the T cell receptor in CD4-CD8- thymocytes from T cell receptor transgenic mice reconstituted with a transgenic CD8 alpha molecule.
    van Oers NS; Teh SJ; Garvin AM; Forbush KA; Perlmutter RM; Teh HS
    J Immunol; 1993 Jul; 151(2):777-90. PubMed ID: 8335907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional similarity and differences between selection-independent CD4-CD8- alphabeta T cells and positively selected CD8 T cells expressing the same TCR and the induction of anergy in CD4-CD8- alphabeta T cells in antigen-expressing mice.
    Caveno J; Zhang Y; Motyka B; Teh SJ; Teh HS
    J Immunol; 1999 Aug; 163(3):1222-9. PubMed ID: 10415017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+ CD8+ thymocytes are preferentially induced to die following CD45 cross-linking, through a novel apoptotic pathway.
    Lesage S; Steff AM; Philippoussis F; Pagé M; Trop S; Mateo V; Hugo P
    J Immunol; 1997 Nov; 159(10):4762-71. PubMed ID: 9366400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
    Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
    J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells expressing receptors of different affinity for antigen ligands reveal a unique role for p59fyn in T cell development and optimal stimulation of T cells by antigen.
    Utting O; Teh SJ; Teh HS
    J Immunol; 1998 Jun; 160(11):5410-9. PubMed ID: 9605142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCR signaling thresholds regulating T cell development and activation are dependent upon SHP-1.
    Johnson KG; LeRoy FG; Borysiewicz LK; Matthews RJ
    J Immunol; 1999 Apr; 162(7):3802-13. PubMed ID: 10201897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequences of increased CD45RA and RC isoforms for TCR signaling and peripheral T cell deficiency resulting from heterogeneous nuclear ribonucleoprotein L-like mutation.
    Wu Z; Yates AL; Hoyne GF; Goodnow CC
    J Immunol; 2010 Jul; 185(1):231-8. PubMed ID: 20505149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans.
    Ratech H; Denning S; Kaufman RE
    Cell Immunol; 1997 May; 177(2):109-18. PubMed ID: 9178637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD45 alternative exon expression in murine and human CD4+ T cell subsets.
    Rogers PR; Pilapil S; Hayakawa K; Romain PL; Parker DC
    J Immunol; 1992 Jun; 148(12):4054-65. PubMed ID: 1351092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use.
    Chang HL; Lefrancois L; Zaroukian MH; Esselman WJ
    J Immunol; 1991 Sep; 147(5):1687-93. PubMed ID: 1831832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses.
    McNeill L; Salmond RJ; Cooper JC; Carret CK; Cassady-Cain RL; Roche-Molina M; Tandon P; Holmes N; Alexander DR
    Immunity; 2007 Sep; 27(3):425-37. PubMed ID: 17719247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor-specific allelic exclusion of TCRV alpha-chains during development.
    Boyd R; Kozieradzki I; Chidgey A; Mittrücker HW; Bouchard D; Timms E; Kishihara K; Ong CJ; Chui D; Marth JD; Mak TW; Penninger JM
    J Immunol; 1998 Aug; 161(4):1718-27. PubMed ID: 9712036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.